2025 HCPCS Code Q2042
Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
TAGS: viable preparation leukapheresis therapeutic million| Short Description | Tisagenlecleucel car-pos t |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | January 01, 2019 |
| HCPCS Action Effective Date | January 01, 2019 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q4140 - Biodfence 1cm
- Q4141 - Alloskin ac, 1 cm
- Q4142 - Xcm biologic tiss matrix 1cm
- Q4143 - Repriza, 1cm
- Q4145 - Epifix, inj, 1mg
- Q4146 - Tensix, 1cm
- Q4147 - Architect ecm px fx 1 sq cm
- Q4148 - Neox neox rt or clarix cord
- Q4149 - Excellagen, 0.1 cc
- Q4150 - Allowrap ds or dry 1 sq cm
- Q4151 - Amnioband, guardian 1 sq cm
- Q4152 - Dermapure 1 square cm
- Q4153 - Dermavest, plurivest sq cm
- Q4154 - Biovance 1 square cm
- Q4155 - Neoxflo or clarixflo 1 mg
- Q4156 - Neox 100 or clarix 100
- Q4157 - Revitalon 1 square cm
- Q4158 - Kerecis omega3, per sq cm
- Q4159 - Affinity1 square cm
- Q4160 - Nushield 1 square cm